1-decene is an alkene that is decane containing one double bond at position 1.
定义
1-decene is an alkene that is decane containing one double bond at position 1. It has a role as a metabolite.
来源: PubChem
美国FDA 物质登记 · UNII 7O4U4C718P · 登记名称 1-Decene · 单一化学物质
化妆品中的作用
调节黏度VISCOSITY CONTROLLING溶解其他成分的基质SOLVENT
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
Other restriction: ban substances that deplete the ozone layer
来源: 欧盟 CosIng 成分清单
详细资料——标示名称、识别编号、物性、试验记录、文献
别名和识别信息
DECENEINCI데센韩国标示名称（食药处标准名）1-Decene同义名
- CAS No.化学物质登记号
- 872-05-9
- EC No.欧盟化学品目录编号
- 212-819-2
- DTXSID美国EPA化学品编号
- DTXSID8027329
- DTXCID美国EPA化合物编号
- DTXCID507329
- IUPAC
- Dec-1-ene
- 分子式
- C10H20
- 分子量
- 140.27 g/mol
实测物性
- 性状
- 液体
- 嗅觉阈值
- 7 ppm
- 熔点/凝固点
- -66.3 ℃
- 初沸点和沸程
- 170.5 ℃
- 闪点
- &, lt, 55 ℃
- 燃烧或爆炸范围上限/下限
- 5.4 / 0.5 %
- 蒸气压
- 1.67 ㎜Hg
- 溶解度
- 0.00057 g/100㎖
- 蒸气密度
- 4.84
- 比重
- 0.7408
- 正辛醇/水分配系数（Kow）
- 5.7
- 自燃温度
- 235 ℃
- 黏度
- 0.75 cP (at 20 ℃)
- 分子量
- 140.266
这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。
来源: 韩国安全保健公团 安全数据表
产品实际使用的用途
这是向美国 EPA 申报含该成分的 13 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。
- Intermediate3
- Viscosity modifier2
- Lubricating agent2
- Fuel2
- Solvent2
- Monomers2
来源: 美国EPA CompTox
刺激与致敏试验记录
记录有皮肤试验 19 项、眼部试验 7 项。
归类为刺激性高5 项归类为中等3 项归类为低31 项
各项试验结论不一（最多的结论占 13%），因此不能断定该成分有刺激性。 这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。
查看全部 26 项试验
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to - Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to - Category 6.3A (Category 2)
Skin Irritation · Read Across - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to - Category 2
Skin Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to - Not classified
Eye Irritation · Screening - Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
来源: 美国EPA CompTox